Ulinastatin-somatostatin combination for acute severe pancreatitis: enhanced clinical efficacy and reduced serum inflammation

Key Points

• Clinical efficacy is notably enhanced when using ulinastatin-somatostatin combination therapy.
• Serum inflammation suppression is achieved effectively with this combination treatment.
• The analysis involved acute severe pancreatitis cases, addressing a significant medical concern.
• Such findings suggest a promising therapeutic approach for managing severe forms of pancreatitis.

Abstract